epirubicin has been researched along with Adenocarcinoma, Scirrhous in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, R; Kimijima, I; Kimura, M; Koyama, H; Miura, S; Nomura, Y; Ohashi, Y; Takashima, S; Takatsuka, Y; Tashiro, H; Toi, M; Tominaga, T | 1 |
| Kanzaki, M; Maeda, M; Matsumoto, K; Miyoshi, S; Takano, Y; Teshima, S; Wakita, T; Yoshinouchi, S | 1 |
| Hamada, K; Kakihara, Y; Kubota, K; Sawada, T; Tagaya, N | 1 |
| Hirata, K; Ohmura, T; Ohshima, H; Okazaki, A; Okazaki, M; Watanabe, Y; Yamamoto, M; Yamashiro, K | 1 |
1 trial(s) available for epirubicin and Adenocarcinoma, Scirrhous
| Article | Year |
|---|---|
Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan.
Topics: Adenocarcinoma; Adenocarcinoma, Scirrhous; Adult; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Carcinoma, Papillary; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Japan; Lymphatic Metastasis; Methotrexate; Middle Aged; Receptors, Estrogen; Survival Rate; Treatment Outcome; Young Adult | 2010 |
3 other study(ies) available for epirubicin and Adenocarcinoma, Scirrhous
| Article | Year |
|---|---|
[Efficacy of FEC and trastuzumab/docetaxel combination therapy for metastatic breast cancer].
Topics: Adenocarcinoma, Scirrhous; Adult; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Neoplasm Metastasis; Taxoids; Trastuzumab | 2010 |
[Docetaxel (TXT), epirubicin (EPI) and doxifluridine (5'-DFUR) combination neoadjuvant chemotherapy for outpatients with locally advanced breast cancer].
Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cystadenocarcinoma, Serous; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Floxuridine; Humans; Middle Aged; Preoperative Care; Taxoids | 2004 |
[Clinical study of selective intra-arterial infusion chemotherapy using trans-radial arterial approach in 4 cases of advanced breast cancer].
Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma, Ductal, Breast; Drug Administration Schedule; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Middle Aged; Neoadjuvant Therapy; Radial Artery | 2000 |